619331-72-5 Usage
Molecular Weight
180.19 g/mol The molecular weight is the mass of one mole of the compound, calculated by adding the atomic weights of all the atoms in the molecular formula.
Structure
1H-Pyrrolo[2,3-c]pyridine core with a carbonitrile group at the 7th position and a methoxy group at the 4th position The structure refers to the arrangement of atoms in the compound, with the pyrrolopyridine core being the central feature and the functional groups attached to it.
Class
Pyrrolopyridine The class refers to the group of organic compounds to which the compound belongs, based on its structural features.
Potential Applications
Pharmaceutical and medicinal chemistry The potential applications refer to the possible uses of the compound in the development of drugs and other biologically active molecules.
Role
Building block or intermediate in the synthesis of biologically active molecules, lead compound for drug discovery The role describes how the compound can be used in the creation of other molecules, either as a starting material or as a reference point for the development of new drugs.
Unique Structure and Chemical Properties
Interesting target for further research and exploration The unique structure and chemical properties make the compound a valuable subject for further study, with the potential for new discoveries and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 619331-72-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,1,9,3,3 and 1 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 619331-72:
(8*6)+(7*1)+(6*9)+(5*3)+(4*3)+(3*1)+(2*7)+(1*2)=155
155 % 10 = 5
So 619331-72-5 is a valid CAS Registry Number.
619331-72-5Relevant articles and documents
Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
-
Page 179-180, (2008/06/13)
This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.
